184 related articles for article (PubMed ID: 15464914)
1. Therapeutic idiotype vaccines for non-Hodgkin's lymphoma.
Timmerman JM
Adv Pharmacol; 2004; 51():271-93. PubMed ID: 15464914
[No Abstract] [Full Text] [Related]
2. The role of idiotype vaccines in the treatment of human B-cell malignancies.
Bendandi M
Expert Rev Vaccines; 2004 Apr; 3(2):163-70. PubMed ID: 15056042
[TBL] [Abstract][Full Text] [Related]
3. Drug evaluation: FavId, a patient-specific idiotypic vaccine for non-Hodgkin's lymphoma.
Reinis M
Curr Opin Mol Ther; 2007 Jun; 9(3):291-8. PubMed ID: 17608028
[TBL] [Abstract][Full Text] [Related]
4. Antibody and immunomodulatory agents in the treatment of indolent non-Hodgkin's lymphoma.
LaCasce AS; Freedman AS
Semin Hematol; 2008 Apr; 45(2):85-9. PubMed ID: 18381102
[TBL] [Abstract][Full Text] [Related]
5. Vaccines for lymphomas: idiotype vaccines and beyond.
Houot R; Levy R
Blood Rev; 2009 May; 23(3):137-42. PubMed ID: 18951668
[TBL] [Abstract][Full Text] [Related]
6. [Past, present and future of anti-idiotype vaccination].
Rodríguez Calvillo M; Inogés S; López Díaz de Cerio A; Zabalegui N; Panizo C; Hernández M; Pérez Calvo J; Prósper F; Melero I; Sánchez-Ibarrola A; Rocha E; Bendandi M
Rev Med Univ Navarra; 2004; 48(3):14-23. PubMed ID: 15622921
[TBL] [Abstract][Full Text] [Related]
7. Idiotype vaccination strategies in myeloma: how to overcome a dysfunctional immune system.
Rhee Fv
Clin Cancer Res; 2007 Mar; 13(5):1353-5. PubMed ID: 17332275
[No Abstract] [Full Text] [Related]
8. Idiotype vaccination in follicular lymphoma: knocking on the doorway to cure.
Longo DL
J Natl Cancer Inst; 2006 Sep; 98(18):1263-5. PubMed ID: 16985240
[No Abstract] [Full Text] [Related]
9. Vaccine therapy for non-Hodgkin's lymphoma and other B-cell malignancies.
Leitch HA; Connors JM
Curr Opin Investig Drugs; 2005 Jun; 6(6):597-604. PubMed ID: 15988911
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic lymphoma vaccines: importance of T-cell immunity.
Neelapu SS; Lee ST; Qin H; Cha SC; Woo AF; Kwak LW
Expert Rev Vaccines; 2006 Jun; 5(3):381-94. PubMed ID: 16827622
[TBL] [Abstract][Full Text] [Related]
11. Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials.
Park HJ; Neelapu SS
Br J Haematol; 2008 Jun; 142(2):179-91. PubMed ID: 18422783
[TBL] [Abstract][Full Text] [Related]
12. Effect of linkage of transduction domain sequences to a lymphoma idiotype DNA vaccine on vaccine effectiveness.
Ashour AK; Petersen JL; McIlhaney MM; Vose JM; Solheim JC
Hybridoma (Larchmt); 2006 Oct; 25(5):306-8. PubMed ID: 17044787
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of idiotype vaccination in relapsed B-cell malignancies.
Inogés S; Rodríguez-Calvillo M; López-Díaz de Cerio A; Zabalegui N; Pérez-Calvo J; Panizo C; Hernandez M; Cuesta B; Rocha E; Bendandi M
Haematologica; 2003 Dec; 88(12):1438-40. PubMed ID: 14688006
[No Abstract] [Full Text] [Related]
14. Idiotype vaccines for non-Hodgkin's lymphoma induce polyclonal immune responses that cover mutated tumor idiotypes: comparison of different vaccine formulations.
Caspar CB; Levy S; Levy R
Blood; 1997 Nov; 90(9):3699-706. PubMed ID: 9345055
[TBL] [Abstract][Full Text] [Related]
15. Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin's lymphoma.
Ruffini PA; Di Nicola M; Carlo-Stella C; Siena S; Gianni AM
Curr Gene Ther; 2005 Oct; 5(5):511-21. PubMed ID: 16250891
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic cancer vaccines.
Morris LF; Ribas A
Surg Oncol Clin N Am; 2007 Oct; 16(4):819-31, ix. PubMed ID: 18022546
[TBL] [Abstract][Full Text] [Related]
17. Excitement tempered by long road ahead for dendritic cell vaccines.
Vanchieri C
J Natl Cancer Inst; 2004 Sep; 96(18):1350-1. PubMed ID: 15367563
[No Abstract] [Full Text] [Related]
18. Idiotype vaccine strategies for treatment of follicular lymphoma.
Mahaseth H; Brody JD; Sinha R; Shenoy PJ; Flowers CR
Future Oncol; 2011 Jan; 7(1):111-22. PubMed ID: 21174542
[TBL] [Abstract][Full Text] [Related]
19. BiovaxID: a personalized therapeutic cancer vaccine for non-Hodgkin's lymphoma.
Lee ST; Jiang YF; Park KU; Woo AF; Neelapu SS
Expert Opin Biol Ther; 2007 Jan; 7(1):113-22. PubMed ID: 17150023
[TBL] [Abstract][Full Text] [Related]
20. Vaccine strategies in the treatment of low-grade non-Hodgkin lymphoma.
Koumarianou A; Kountourakis P; Economopoulos T
J Steroid Biochem Mol Biol; 2008 Apr; 109(3-5):230-2. PubMed ID: 18406604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
